Applied DNA Sciences Inc Debt to Equity Ratio 2010-2024 | APDN
Current and historical debt to equity ratio values for Applied DNA Sciences Inc (APDN) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Applied DNA Sciences Inc debt/equity for the three months ending June 30, 2024 was 0.00.
Applied DNA Sciences Inc Debt/Equity Ratio Historical Data |
Date |
Long Term Debt |
Shareholder's Equity |
Debt to Equity Ratio |
2024-06-30 |
$0.00B |
$0.01B |
0.36 |
2024-03-31 |
$0.01B |
$0.00B |
-53.31 |
2023-12-31 |
$0.01B |
$0.00B |
1.40 |
2023-09-30 |
$0.01B |
$0.01B |
1.80 |
2023-06-30 |
$0.01B |
$0.01B |
1.20 |
2023-03-31 |
$0.01B |
$0.01B |
0.92 |
2022-12-31 |
$0.01B |
$0.01B |
1.22 |
2022-09-30 |
$0.01B |
$0.01B |
0.73 |
2022-06-30 |
$0.01B |
$0.01B |
0.75 |
2022-03-31 |
$0.01B |
$0.01B |
0.82 |
2021-12-31 |
$0.00B |
$0.01B |
0.36 |
2021-09-30 |
$0.00B |
$0.01B |
0.30 |
2021-06-30 |
$0.00B |
$0.02B |
0.10 |
2021-03-31 |
$0.00B |
$0.02B |
0.12 |
2020-12-31 |
$0.00B |
$0.01B |
0.69 |
2020-09-30 |
$0.01B |
$0.01B |
0.99 |
2020-06-30 |
$0.01B |
$0.01B |
0.59 |
2020-03-31 |
$0.00B |
$0.01B |
0.56 |
2019-12-31 |
$0.00B |
$0.01B |
0.51 |
2019-09-30 |
$0.00B |
$-0.00B |
-5.20 |
2019-06-30 |
$0.01B |
$-0.00B |
-2.67 |
2019-03-31 |
$0.01B |
$-0.00B |
-6.75 |
2018-12-31 |
$0.01B |
$0.00B |
7.03 |
2018-09-30 |
$0.01B |
$0.00B |
6.47 |
2018-06-30 |
$0.00B |
$0.00B |
1.16 |
2018-03-31 |
$0.00B |
$0.01B |
0.39 |
2017-12-31 |
$0.00B |
$0.01B |
0.18 |
2017-09-30 |
$0.00B |
$0.01B |
0.19 |
2017-06-30 |
$0.00B |
$0.01B |
0.30 |
2017-03-31 |
$0.00B |
$0.01B |
0.42 |
2016-12-31 |
$0.01B |
$0.01B |
0.38 |
2016-09-30 |
$0.01B |
$0.01B |
0.50 |
2016-06-30 |
$0.00B |
$0.01B |
0.25 |
2016-03-31 |
$0.00B |
$0.02B |
0.18 |
2015-12-31 |
$0.00B |
$0.02B |
0.14 |
2015-09-30 |
$0.00B |
$0.01B |
0.24 |
2015-06-30 |
$0.00B |
$0.01B |
0.13 |
2015-03-31 |
$0.00B |
$0.00B |
0.86 |
2014-12-31 |
$0.00B |
$0.00B |
0.52 |
2014-09-30 |
$0.01B |
$-0.00B |
-3.39 |
2014-06-30 |
$0.00B |
$0.00B |
11.12 |
2014-03-31 |
$0.00B |
$0.00B |
-12.81 |
2013-12-31 |
$0.00B |
$0.00B |
2.32 |
2013-09-30 |
$0.00B |
$0.01B |
0.81 |
2013-06-30 |
$0.00B |
$0.00B |
0.67 |
2013-03-31 |
$0.01B |
$-0.00B |
-2.35 |
2012-12-31 |
$0.01B |
$-0.01B |
-1.24 |
2012-09-30 |
$0.00B |
$0.00B |
0.78 |
2012-06-30 |
$0.00B |
$0.00B |
0.50 |
2012-03-31 |
$0.00B |
$0.00B |
0.78 |
2011-12-31 |
$0.00B |
$-0.00B |
-2.86 |
2011-09-30 |
$0.00B |
$-0.00B |
-4.52 |
2011-06-30 |
$0.01B |
$-0.00B |
-1.23 |
2011-03-31 |
$0.00B |
$-0.00B |
-1.58 |
2010-12-31 |
$0.00B |
$-0.00B |
-1.98 |
2010-09-30 |
$0.00B |
$-0.00B |
-1.88 |
2010-06-30 |
$0.00B |
$-0.00B |
-1.41 |
2010-03-31 |
$0.00B |
$-0.00B |
-1.34 |
2009-12-31 |
$0.00B |
$-0.00B |
-1.39 |
2009-09-30 |
$0.00B |
$-0.00B |
-1.86 |
2009-06-30 |
$0.00B |
$-0.00B |
-2.69 |
2009-03-31 |
$0.00B |
$0.00B |
-10.17 |
Sector |
Industry |
Market Cap |
Revenue |
Industrial Products |
Protection - Safety Equipment & Services |
$0.010B |
$0.003B |
Applied DNA Sciences, Inc. provides proprietary DNA-embedded biotechnology security solutions, using non-human DNA, that verify authenticity and protect corporate and government agencies from counterfeiting, fraud, piracy, product diversion, identity theft and unauthorized intrusion. They develop, market, and sub-license DNA security systems, supply-chain management systems and anti-counterfeit solutions. Applied DNA Sciences has an exclusive licensing and partnership agreement covering North America and Europe with Biowell Technology, Inc. of Taiwan.
|